Califf Sets Exit At FDA, Ostroff Could Return To Acting Commissioner Post
This article was originally published in The Rose Sheet
Executive Summary
Former acting commissioner in line for the temporary position again under FDA policy, unless incoming Trump administration designates someone else.
You may also be interested in...
Gottlieb Becomes FDA Commissioner With Immediate Issues Pending
Confirmation comes with fewest votes of any recent commissioner as FDA faces pressing budget, user-fee and other issues. The Personal Care Products Council welcomed Gottlieb to the post and took the occasion to plug cosmetics industry virtues at a time when legislation is under consideration to update regulations.
US FDA’s OCI Director Is Leaving For Private Practice
George Karavetsos’ last day is Jan. 20, which coincidentally is the start of the Trump Administration. Office of Criminal Investigations has been subject of recent Congressional scrutiny.
Woodcock Tries To Calm US FDA Staff Fears About Trump
CDER Director's' video advises focusing on the work and "keeping our heads down."